Prolongation of cardiac QT due to erythromycin compare to Placebo reported as Delta QTcf 1hour and 20 minutes [clinicaltrials_resource:912c61515e524cda7cf612611af536d1]
Delta QTcf is measured at H0, H0+20 minutes, and H0+1h20, on groups' erythromycin and placebo. QTcf may be adjusted based on the pharmacokinetic data to ensure time of the plasmatic pick is used.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Prolongation of cardiac QT due to erythromycin compare to Placebo reported as Delta QTcf 1hour and 20 minutes [clinicaltrials_resource:912c61515e524cda7cf612611af536d1]
Delta QTcf is measured at H0, H0+20 minutes, and H0+1h20, on groups' erythromycin and placebo. QTcf may be adjusted based on the pharmacokinetic data to ensure time of the plasmatic pick is used.
Bio2RDF identifier
912c61515e524cda7cf612611af536d1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:912c61515e524cda7cf612611af536d1
measure [clinicaltrials_vocabulary:measure]
Prolongation of cardiac QT due ...... acebo reported as Delta QTcf
time frame [clinicaltrials_vocabulary:time-frame]
1hour and 20 minutes
description
Delta QTcf is measured at H0, ...... of the plasmatic pick is used.
identifier
clinicaltrials_resource:912c61515e524cda7cf612611af536d1
title
Prolongation of cardiac QT due ...... lta QTcf 1hour and 20 minutes
@en
type
label
Prolongation of cardiac QT due ...... c61515e524cda7cf612611af536d1]
@en